1
ALL1
Anglo-French Drugs and industriesYear
1
ALL1
2022DEALS // DEV.
1
ALL1
DealsCountry
1
ALL1
INDIA1
ALL1
Lupin LtdTherapeutic Area
1
ALL1
Nutrition and Weight LossStudy Phase
1
ALL1
Approved FDFDeal Type
1
ALL1
AcquisitionProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
Oral TabletLead Product
1
ALL1
NicotinamideTarget
1
ALL1
Fatty-acid amide hydrolase 1Lead Product(s) : Nicotinamide
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Lupin Ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Lupin Completes Acquisition of Brands from Anglo-French
Details : The acquisition will strengthen Lupin’s business by adding a portfolio of vitamins, minerals, supplements and neurological products. The acquisition of the AFDIL brands takes Lupin further in shaping its portfolio to emerge as a leading pharmaceutical ...
Product Name : Beplex Forte
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 04, 2022
Lead Product(s) : Nicotinamide
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Lupin Ltd
Deal Size : Undisclosed
Deal Type : Acquisition